Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  T2 Biosystems Inc    TTOO

T2 BIOSYSTEMS INC (TTOO)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/15/2018 06/18/2018 06/19/2018 06/20/2018 06/21/2018 Date
9.58(c) 9.25(c) 8.91(c) 8.16(c) 8.04 Last
1 062 079 598 555 793 272 1 281 967 125 956 Volume
+1.48% -3.44% -3.68% -8.42% -1.47% Change
More quotes
Financials (USD)
Sales 2018 10,5 M
EBIT 2018 -44,5 M
Net income 2018 -50,9 M
Debt 2018 10,3 M
Yield 2018 -
Sales 2019 21,0 M
EBIT 2019 -37,6 M
Net income 2019 -44,4 M
Debt 2019 17,9 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 31,5x
EV / Sales2019 16,1x
Capitalization 321 M
More Financials
Company
T2 Biosystems, Inc. engages in the development of proprietary technology platform.It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum,... 
More about the company
Surperformance© ratings of T2 Biosystems Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on T2 BIOSYSTEMS INC
06/13T2 BIOSYSTEMS, INC. : Changes in Registrant's Certifying Accountant, Financial S..
AQ
06/13Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel ..
GL
06/12T2 BIOSYSTEMS, INC. : Submission of Matters to a Vote of Security Holders (form ..
AQ
06/06RECENT BREAKTHROUGH IN SEPSIS PATHOG : Same-Day Results with T2Direct Diagnostic..
AQ
06/06T2 BIOSYSTEMS : Announces Closing of Public Offering of Common Stock
AQ
06/06T2 Biosystems Reports Granting of Inducement Awards
GL
06/05T2 Biosystems Announces Closing of Public Offering of Common Stock
GL
06/04T2 BIOSYSTEMS, INC. : Results of Operations and Financial Condition, Financial S..
AQ
06/04T2 BIOSYSTEMS, INC. : Entry into a Material Definitive Agreement, Financial Stat..
AQ
06/01T2 BIOSYSTEMS : to Present at the Jefferies 2018 Global Healthcare Conference
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
06/12STRYKER : Approaches Rival Boston Scientific for Deal -- WSJ
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
06/18T2 Biosystems $TTOO Rating Reiterated by HC Wainwright  
06/17T2 Biosystems $TTOO Earns Buy Rating from HC Wainwright  
06/16T2 Biosystems $TTOO Sets New 1-Year High at $9.98  
06/14H.C. Wainwright Believes T2 Biosystems (NASDAQ: TTOO) Still Has Room to Grow .. 
06/08T2 Biosystems Inc $TTOO Director Sells $53,220.00 in Stock  
More tweets
Qtime:91
News from SeekingAlpha
06/18T2 Biosystems By The Numbers 
06/15T2 BIOSYSTEMS : Still A Buy After The Rally 
06/08Midday Gainers / Losers (06/08/2018) 
06/04After Hours Gainers / Losers (06/04/2018) 
06/03T2 BIOSYTEMS : The Story Is Just Beginning 
Chart T2 BIOSYSTEMS INC
Duration : Period :
T2 Biosystems Inc Technical Analysis Chart | TTOO | US89853L1044 | 4-Traders
Technical analysis trends T2 BIOSYSTEMS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 12,3 $
Spread / Average Target 51%
EPS Revisions
Managers
NameTitle
John P. McDonough President, Chief Executive Officer & Director
Alec Barclay Senior Vice President-Operations
John M. Sprague Chief Financial Officer
Thomas Jay Lowery Chief Scientific Officer
Michael J. Cima Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
T2 BIOSYSTEMS INC98.06%321
MEDTRONIC PLC7.26%117 389
BAXTER INTERNATIONAL14.74%39 889
ALIGN TECHNOLOGY64.38%29 274
TERUMO CORP27.51%23 535
ZIMMER BIOMET HOLDINGS-7.11%22 728